MOUNTAIN VIEW, Calif., April 1, 2015 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions for healthcare institutions, today announced it had received notification from the Nasdaq Stock Market that the Company is now in compliance with Nasdaq Listing Rule 5250(c)(1), based on the March 30, 2015 filing of Omnicell's Form 10-K for the period ended December 31, 2014. Nasdaq indicated the matter is now closed.
On March 18, 2015, the Company received notice from Nasdaq that the Company was not in compliance with the listing rule, due to the delay in filing its Annual Report on Form 10-K, beyond the extended filing due date of March 17, 2015. Omnicell filed its Form 10-K on March 30, 2015 to conclude the matter.
Since 1992, Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum - from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
More than 3,000 customers worldwide have utilized Omnicell Automation and Analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Medication Adherence solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please visit www.omnicell.com.
Logo - http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/omnicell-regains-nasdaq-listing-compliance-300059182.html
SOURCE Omnicell, Inc.